Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Establishing Cutoffs for Streptococcal Antibody Titers in Uganda: Implications for Rheumatic Fever Diagnosis

Emmy Okello, Meghna Murali, Joselyn Rwebembera, Jenifer Atala, Nada Harik, Gloria Kaudha, Samalie Kitooleko, Chris T Longenecker, Emma Ndagire, Isaac Otim Omara, Linda Mary Oyella, Tom Parks, Jafes Pulle, Craig Sable, Rachel Sarnacki, Elizabeth Stein, Meghan Zimmerman, Nicholas de Klerk, Jonathan Carapetis, Andrea Beaton
doi: https://doi.org/10.1101/19010447
Emmy Okello
1Uganda Heart Institute, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meghna Murali
2Children’s National Hospital, 111 Michigan Avenue NW Washington DC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joselyn Rwebembera
1Uganda Heart Institute, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenifer Atala
1Uganda Heart Institute, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nada Harik
2Children’s National Hospital, 111 Michigan Avenue NW Washington DC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gloria Kaudha
1Uganda Heart Institute, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samalie Kitooleko
1Uganda Heart Institute, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris T Longenecker
3University Hospitals Harrington Heart & Vascular Institute and Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland OH, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Ndagire
1Uganda Heart Institute, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isaac Otim Omara
1Uganda Heart Institute, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Mary Oyella
1Uganda Heart Institute, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Parks
4Department of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jafes Pulle
1Uganda Heart Institute, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig Sable
2Children’s National Hospital, 111 Michigan Avenue NW Washington DC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Sarnacki
1Uganda Heart Institute, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rsarnack@cnmc.org
Elizabeth Stein
2Children’s National Hospital, 111 Michigan Avenue NW Washington DC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meghan Zimmerman
2Children’s National Hospital, 111 Michigan Avenue NW Washington DC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas de Klerk
5Telethon Kids Institute, 15 Hospital Avenue, Perth Children’s Hospital, Perth, WA, Australia; Perth Children’s Hospital, Perth, WA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Carapetis
5Telethon Kids Institute, 15 Hospital Avenue, Perth Children’s Hospital, Perth, WA, Australia; Perth Children’s Hospital, Perth, WA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Beaton
6Cincinnati Children’s Hospital Medical Center, The Heart Institute, 3333 Burnet Avenue, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Central to rheumatic fever (RF) diagnosis is evidence of streptococcal exposure, specifically antistreptolysin O (ASO) and antideoxyribonuclease B (ADB) antibodies. It is unknown if these antibody titers should be adjusted to the background exposure rates of GAS or if published standards should be used. Here, we establish the normal values of ASO and ADB in Uganda and examine RF case detection using published vs. population-specific thresholds.

Methods Participants (age 0-50 years) were recruited. ASO was measured in-country by nephelometric technique. ADB samples were sent to Australia (PathWest) for ADB determination by enzyme inhibition assay, andthe 80% upper limit values by age were established. The published standard values for ASO (200IU/ml) and ADB (375IU/ml) were compared to the Ugandan 80% upper limit of normal values (ULN) for RF case detection in children 5-15 years.

Findings Of the 428 participants, 16 were excluded from analysis (9 sore throat, 1 skin sores, 5 fever, 4 echocardiograms showing occult RHD), and 183 of the remaining were children 5-15 years. The median ASO titer in this age group was 220 IU/ml, with the 80th percentile value of 389 IU/ml. The median ADB titer in this age group was 375 IU/ml, with the 80th percentile value of 568 IU/ml. Application of new Ugandan cutoffs to 528 children enrolled in our prospective RF study, reduced the number of definite RF cases to 120/528 (22·7%), as compared to 173/528 (32·8%) using published normal values.

Interpretation The 80th percentile ULN for ASO and ADB are higher in Uganda than in other countries. Applying these higher values to RF diagnosis in Uganda results in higher diagnostic specificity, but some unknown loss in sensitivity. Implications of over-diagnosis and missed cases will be explored through a longitudinal follow-up study of children in the RF research program.

Funding This work was supported by American Heart Association Grant #17SFRN33670607 / Andrea Beaton / 2017 and DELTAS Africa Initiative.

Evidence before this study We searched PubMed for data on normal values of streptococcal antibody titers within diverse populations between database inception and January 1, 2019, using the search terms (rheumatic fever) OR (streptococcal antibodies). Nine studies were identified, but only one was from sub-Saharan Africa (2018, Ethiopia) and it was limited by vague exclusion criteria and lack of data on anti-DNase B. Given the high burden of rheumatic heart disease in sub-Saharan Africa, further data is needed to determine normal streptococcal antibody titers in this population and to assess the clinical impact of different cutoffs for RF diagnosis.

Added value of this study Our study utilized a rigorous approach to exclude patients with history of recent possible streptococcal exposure including skin and throat infection and employed echocardiography to exclude patients with pre-existing rheumatic heart disease. Additionally, this study was conducted in parallel to a larger epidemiological cohort study of rheumatic fever in Uganda, allowing us, for the first time, to prospectively determine how utilization of different streptococcal antibody titer cutoffs affect diagnosis of rheumatic fever.

Implications of all the available evidence Rheumatic fever remains a challenging diagnosis based on a clinical decision rule with imperfect sensitivity and specificity. Improved understanding of streptococcal antibody titers in rheumatic heart disease endemic populations may improve diagnostic performance. Our study also points to the need for development of a rheumatic fever diagnostic test, in order to provide a more definitive assessment of risk.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by American Heart Association Grant #17SFRN33670607 / Andrea Beaton / 2017 and by DELTAS Africa Initiative. The investigators would like to thank General Electric Healthcare for providing echocardiography equipment.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Study data will not be publicly available. Any data requests should be made to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 29, 2019.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Establishing Cutoffs for Streptococcal Antibody Titers in Uganda: Implications for Rheumatic Fever Diagnosis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Establishing Cutoffs for Streptococcal Antibody Titers in Uganda: Implications for Rheumatic Fever Diagnosis
Emmy Okello, Meghna Murali, Joselyn Rwebembera, Jenifer Atala, Nada Harik, Gloria Kaudha, Samalie Kitooleko, Chris T Longenecker, Emma Ndagire, Isaac Otim Omara, Linda Mary Oyella, Tom Parks, Jafes Pulle, Craig Sable, Rachel Sarnacki, Elizabeth Stein, Meghan Zimmerman, Nicholas de Klerk, Jonathan Carapetis, Andrea Beaton
medRxiv 19010447; doi: https://doi.org/10.1101/19010447
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Establishing Cutoffs for Streptococcal Antibody Titers in Uganda: Implications for Rheumatic Fever Diagnosis
Emmy Okello, Meghna Murali, Joselyn Rwebembera, Jenifer Atala, Nada Harik, Gloria Kaudha, Samalie Kitooleko, Chris T Longenecker, Emma Ndagire, Isaac Otim Omara, Linda Mary Oyella, Tom Parks, Jafes Pulle, Craig Sable, Rachel Sarnacki, Elizabeth Stein, Meghan Zimmerman, Nicholas de Klerk, Jonathan Carapetis, Andrea Beaton
medRxiv 19010447; doi: https://doi.org/10.1101/19010447

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (44)
  • Cardiovascular Medicine (409)
  • Dentistry and Oral Medicine (68)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4818)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (671)
  • Geriatric Medicine (70)
  • Health Economics (188)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (85)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5287)
  • Intensive Care and Critical Care Medicine (327)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (112)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (203)
  • Oncology (439)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (128)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (771)
  • Public and Global Health (1800)
  • Radiology and Imaging (322)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)